Sign in
Update to the Long-Term Efficacy and Safety of Iptacopan in C3 Glomerulopathy: 39-Month Phase 2 Extension Study Data: FR-PO0837
Abstract   Peer reviewed

Update to the Long-Term Efficacy and Safety of Iptacopan in C3 Glomerulopathy: 39-Month Phase 2 Extension Study Data: FR-PO0837

Carla M. Nester, Ute Eisenberger, Alexandre Karras, Moglie Le Quintrec, Liz Lightstone, Manuel Praga, Giuseppe Remuzzi, Maria Jose Soler Romeo, Junhao Liu, Rubeen K. Israni, …
Journal of the American Society of Nephrology, Vol.36(10S)
10/2025
DOI: 10.1681/ASN.2025ztfh1kk4

View Online

Details

Metrics

1 Record Views
Logo image